Samuel Ross Mansbach's most recent trade in Establishment Labs Holdings Inc was a trade of 657 Common Shares done at an average price of $70.4 . Disclosure was reported to the exchange on March 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | General Counsel and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.41 per share. | 06 Mar 2026 | 657 | 18,663 (0%) | 0% | 70.4 | 46,259 | Common Shares |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2026 | 7,131 | 7,131 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2026 | 4,082 | 19,320 (0%) | 0% | 0 | Common Shares | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 13,998 | 13,998 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | General Counsel and CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Mar 2025 | 7,952 | 15,238 (0%) | 0% | 0 | Common Shares | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | General Counsel and CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. | 06 Mar 2025 | 728 | 7,286 (0%) | 0% | 42.1 | 30,634 | Common Shares |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 7,691 | 7,691 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 7,691 | 7,691 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 5,406 | 10,812 (0%) | 0% | 0 | Common Shares | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 5,406 | 8,014 (0%) | 0% | 0 | Common Shares | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.25 per share. | 06 Mar 2024 | 252 | 2,608 (0%) | 0% | 49.3 | 12,411 | Common Shares |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 6,933 | 6,933 | - | - | Stock Option (Right to buy) | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 2,860 | 2,860 (0%) | 0% | 0 | Common Shares | |
| Establishment Labs Holdings Inc | Samuel Ross Mansbach | GC & Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2022 | 34,796 | 34,796 | - | - | Stock Option (Right to buy) |